Physician profile
Deborah D Barton
NPI 1548234222
$3,776.67
in general payments reported to CMS, 2019-2025
19 companies · $39.69 in 2025
The $39.69 reported for 2025 was less than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,514 · 2022: $797 · 2023: $278 · 2024: $147 · 2025: $39.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,725.77 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $411.01 | 2021-2023 | Uptravi, Opsumit |
| Medtronic, INC. | $385.87 | 2021-2022 | |
| Amgen INC. | $179.82 | 2021-2023 | Repatha |
| Novartis Pharmaceuticals Corporation | $158.79 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.82 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $140.38 | 2021-2024 | Camzyos |
| Pfizer INC. | $114.48 | 2021 | |
| Merck Sharp & Dohme LLC | $85.70 | 2021-2022 | |
| Tactile Systems Technology INC | $79.83 | 2021 | |
| Alexion Pharmaceuticals, INC. | $67.45 | 2022 | |
| Boston Scientific Corporation | $65.45 | 2021-2023 | |
| Biogen, INC. | $53.01 | 2022 | |
| Janssen Pharmaceuticals, INC | $50.99 | 2021-2022 | |
| Esperion Therapeutics, INC. | $33.92 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $31.03 | 2022 | |
| Chiesi USA, INC. | $23.24 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.03 | 2022 | |
| Alnylam Pharmaceuticals INC. | $13.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Barton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.